Astigmatism Management in Cataract Surgery With the AcrySof Toric Intraocular Lens

January 13, 2014 updated by: Maastricht University Medical Center

Efficacy and Cost-effectiveness of Toric Intraocular Lenses in Correcting Astigmatism in Cataract Surgery: a Randomised Clinical Trial

The purpose of this study is to determine if Toric intraocular lens implantation in cataract surgery is a more efficient and cost-effective treatment of astigmatism than Monofocal intraocular lens implantation.

Study Overview

Detailed Description

A recent innovation in cataract surgery consists of the introduction of toric intraocular lenses (IOLs) that can correct corneal astigmatism. It offers the opportunity for patients with substantial astigmatism to achieve optimal distance vision without using spectacles. Good near vision may subsequently be achieved with low-cost reading glasses. The current practice of non-toric IOL implantation in astigmatic patients warrants the use of expensive bifocal or multifocal spectacles with cylinder correction to achieve good distance and near vision.

Objective: The primary objective of this study is to compare spectacle independence for distance vision following toric IOL implantation and monofocal intraocular lens (IOL) implantation. The secondary objectives are to compare uncorrected distance vision, residual refractive astigmatism, quality of vision, wavefront aberrations, contrast sensitivity, complication profile, costs of postoperative spectacles and cost-effectiveness.

Study design: Multi-centre randomised clinical trial. Study population: 160 patients with regular corneal astigmatism of at least 1.25 diopters in both eyes who require bilateral cataract surgery.

Intervention: Cataract surgery with implantation of a toric IOL (AcrySof model SN60TT) or an monofocal IOL (AcrySof model SN60AT).

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Heerlen, Brunssum, Kerkrade, Netherlands
        • Atrium Medical Center
      • Maastricht, Netherlands, 6229 HX
        • Maastricht University Medical Center
      • Rotterdam, Netherlands
        • Rotterdam Eye Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Bilateral cataract
  • Bilateral corneal astigmatism (at least 1.25D)
  • Predicted residual astigmatism less than 0.5D

Exclusion Criteria:

  • Irregular corneal astigmatism or keratoconus
  • Fuchs endothelial dystrophy (stage 2)
  • Expected postoperative best-corrected visual acuity worse than logMAR +0.3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Toric intraocular lens
Bilateral Toric intraocular lens implantation in cataract surgery
The lens is made of foldable acrylic material and is implanted in the capsular bag
Other: Monofocal intraocular lens
Bilateral Monofocal intraocular lens implantation in cataract surgery
The lens is made of foldable acrylic material and is implanted in the capsular bag

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spectacle independency
Time Frame: preop, 3 months and 6 months postop
Spectacle independency for distance vision
preop, 3 months and 6 months postop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual acuity
Time Frame: preop, 1 day, 1 month, 3 months and 6 months postop
preop, 1 day, 1 month, 3 months and 6 months postop
Refractive astigmatism
Time Frame: preop, 3 months and 6 months postop
preop, 3 months and 6 months postop
Higher-order wavefront aberrations
Time Frame: preop, 3 months and 6 months postop
preop, 3 months and 6 months postop
Contrast sensitivity
Time Frame: preop, 3 months and 6 months postop
preop, 3 months and 6 months postop
Costs related to intervention
Time Frame: preop, 3 and 6 months postop
Total cost-analysis, including out-of-hospital costs for patient
preop, 3 and 6 months postop
Quality of vision
Time Frame: preop, 3 months, 6 months
Refractive-error related quality of vision
preop, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rudy Nuijts, MD, PhD, Maastricht University Medical Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

February 24, 2010

First Submitted That Met QC Criteria

February 24, 2010

First Posted (Estimate)

February 25, 2010

Study Record Updates

Last Update Posted (Estimate)

January 14, 2014

Last Update Submitted That Met QC Criteria

January 13, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 082099

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on AcrySof Toric intraocular lens, model SN60TT

3
Subscribe